文献速递眼底病与葡萄膜炎

残余视网膜下液体积对SRF耐受性T&E方案治疗结局的影响

IMPACT OF RESIDUAL SUBRETINAL FLUID VOLUMES ON TREATMENT OUTCOMES IN A SUBRETINAL FLUID-TOLERANT TREAT-AND-EXTEND REGIMEN.
PubMed 文献 · Retina · 2021-01-01

本研究基于前瞻性多中心FLUID研究,纳入98例接受SRF耐受性T&E方案治疗的新生血管性年龄相关性黄斑变性患者,利用人工智能量化视网膜下液体积。分析375次随访发现,尽管存在残余SRF仍延长间隔时,SRF体积增加与下次访视BCVA下降相关,且延长间隔与BCVA变化呈负相关。

要点

  • 在SRF耐受性T&E方案中,残余SRF体积增加与下次访视BCVA降低相关
  • 延长治疗间隔与BCVA变化呈负相关,尤其当存在残余SRF时
  • AI量化SRF体积有助于评估T&E方案下的治疗结局

核心结论

  • 基于AI的分析显示,尽管存在残余SRF仍延长访视间隔时,SRF体积增加与连续访视时BCVA下降相关。

研究设计与样本

  • 前瞻性多中心FLUID研究的事后分析,纳入98例接受SRF耐受性T&E方案治疗的新生血管性AMD患者,共375次访视。
  • 使用光谱域OCT和AI工具量化视网膜内液和SRF体积,并测量BCVA。
  • 访视分为两组:尽管存在残余SRF仍延长间隔组和无液体延长间隔组。

主要发现

  • 在尽管存在残余SRF仍延长间隔组,SRF增加与下次访视BCVA降低相关:中央1mm为-0.138字母/nL(P=0.014),6mm为-0.024字母/nL(P=0.049)。
  • 延长间隔与BCVA变化呈负相关:1mm和6mm的SRF分别为-0.250和-0.233字母/周间隔(均P<0.001)。
  • 尽管存在残余SRF仍延长间隔组在下次访视时中央6mm SRF体积显著更高(P=0.002)。

临床怎么用

  • 在SRF耐受性T&E方案中,应关注残余SRF体积,尤其当计划延长治疗间隔时。
  • AI量化SRF体积可辅助评估延长间隔后BCVA下降的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate associations between residual subretinal fluid (rSRF) volumes, quantified using artificial intelligence and treatment outcomes in a subretinal fluid (SRF)-tolerant treat-and-extend (T&E) regimen in neovascular age-related macular degeneration. METHODS: Patients enrolled in the prospective, multicenter FLUID study randomized in an SRF-tolerant T&E regimen were examined by spectral-domain optical coherence tomography and tested for best-corrected visual acuity (BCVA). Intraretinal fluid and SRF volumes were quantified using artificial intelligence tools. In total, 375 visits of 98 patients were divided into subgroups: extended intervals despite rSRF and extended intervals without fluid. Associations between BCVA change, SRF volume, subgroups, and treatment intervals were estimated using linear mixed models. RESULTS: In extended intervals despite rSRF, increased SRF was associated with reduced BCVA at the next visit in the central 1 mm (-0.138 letters per nL; P = 0.014) and 6 mm (-0.024 letters per nL; P = 0.049). A negative association between increased interval and BCVA change was found for rSRF in 1 mm and 6 mm (-0.250 and -0.233 letter per week interval, respectively; both P < 0.001). Extended intervals despite rSRF had significantly higher SRF volumes in the central 6 mm at the following visit (P = 0.002). CONCLUSION: Artificial intelligence-based analysis of extended visits despite rSRF demonstrated increasing SRF volumes associated with BCVA loss at the consecutive visit. This negative association contributes to the understanding of rSRF volumes on treatment outcomes in neovascular age-related macular degeneration.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Grechenig C, Reiter GS, Riedl S, et al. IMPACT OF RESIDUAL SUBRETINAL FLUID VOLUMES ON TREATMENT OUTCOMES IN A SUBRETINAL FLUID-TOLERANT TREAT-AND-EXTEND REGIMEN. Retina. 2021. PMID: 33830960. doi:10.1097/IAE.0000000000003180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。